- Home
- HKIT vs CALC Comparison
HKIT vs CALC Comparison
Compare HKIT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- CALC
- Stock Information
- Founded
- HKIT 1996
- CALC 2011
- Country
- HKIT China
- CALC United States
- Employees
- HKIT N/A
- CALC N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- CALC Health Care
- Exchange
- HKIT Nasdaq
- CALC Nasdaq
- Market Cap
- HKIT 39.8M
- CALC 22.9M
- IPO Year
- HKIT 2023
- CALC N/A
- Fundamental
- Price
- HKIT $1.43
- CALC $2.13
- Analyst Decision
- HKIT
- CALC Strong Buy
- Analyst Count
- HKIT 0
- CALC 2
- Target Price
- HKIT N/A
- CALC $14.50
- AVG Volume (30 Days)
- HKIT 8.2K
- CALC 38.7K
- Earning Date
- HKIT 04-29-2025
- CALC 08-11-2025
- Dividend Yield
- HKIT N/A
- CALC N/A
- EPS Growth
- HKIT N/A
- CALC N/A
- EPS
- HKIT N/A
- CALC N/A
- Revenue
- HKIT $2,904,950.00
- CALC N/A
- Revenue This Year
- HKIT N/A
- CALC N/A
- Revenue Next Year
- HKIT N/A
- CALC N/A
- P/E Ratio
- HKIT N/A
- CALC N/A
- Revenue Growth
- HKIT N/A
- CALC N/A
- 52 Week Low
- HKIT $1.15
- CALC $1.42
- 52 Week High
- HKIT $1.86
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- HKIT 60.28
- CALC 48.14
- Support Level
- HKIT $1.33
- CALC $1.59
- Resistance Level
- HKIT $1.45
- CALC $1.69
- Average True Range (ATR)
- HKIT 0.05
- CALC 0.15
- MACD
- HKIT 0.01
- CALC 0.01
- Stochastic Oscillator
- HKIT 100.00
- CALC 46.51
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.